Opioid Use and Predicting Factors at the Emergency Department (VRxOPUS-1)

Radboud University Medical Center

Status: Completed

Conditions: Pain, Acute; Pain

Treatments: Other: Usual care

Study type: Observational

Funder types: Other

Identifiers

NCT06072950

113728

Details and patient eligibility

About

Background: Increasing opioid misuse is a worldwide problem. About 10% of opioid misusers are primarily exposed to opioids at the Emergency Department (ED). This study was conducted to determine the feasibility for a clinical trial investigating the effect of Virtual Reality therapy on opioid consumption at the ED.

Methods: Adult patients were included when primarily seen by the Emergency Physician and presenting with a NRS pain score ≥4. Main objective was to identify the target population and evaluate outcome measures to sustain a trial incorporating the Oral Morphine Equivalent (OME) at the ED as the primary endpoint. Primary outcome was mean OME administered at the ED. Secondary outcomes included NRS pain scores, main symptoms and type of analgesics administered at the ED.

Enrollment: 149 patients

Sex: All

Ages: 16 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient ≥16 years admitted to ED and identified by an Emergency Physician (EP)
• NRS pain score ≥4
• Patient is willing and able to comply with the study protocol

Exclusion criteria

• Patients initially treated by another physician than the EP.
• EMV < 14
• History of dementia, seizures
• Severe hearing/visual impairment not corrected
• Headwounds or damaged skin with which comfortable and hygienic use is not possible.
• Presentation to ED because of chronic pain (≥3 months) exacerbation
• Chronic opioids use (≥3 months)

Trial design

149 participants in 1 patient group

Patient with NRS pain at rest being 4 or higher

Description:

Patient with NRS pain at rest being 4 or higher, primarily treated by emergency physician, internist, or surgeon. All patients receive usual care, no interventions are administered.

Treatment:

Other: Usual care